ResMed (RMD) Earnings Date, Estimates & Call Transcripts $212.89 +1.40 (+0.66%) Closing price 04/17/2025 03:59 PM EasternExtended Trading$210.14 -2.75 (-1.29%) As of 04/17/2025 04:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ResMed Earnings Summary Upcoming Q3 Earnings DateApr. 23Before Market OpensEstimatedConsensus EPS (Jan. 30) $2.29 Actual EPS (Jan. 30) $2.43 Beat By $0.14 ResMed announced Q2 2025 earnings on January 30, 2025, reporting an EPS of $2.43, which beat analysts' consensus estimates of $2.29 by $0.14. With a trailing EPS of $8.47 and a P/E Ratio of 25.13, ResMed's earnings are expected to grow 9.40% next year, from $9.47 to $10.36 per share. Q2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Slide Deck Quarterly Report (10-Q)RMD Upcoming EarningsResMed's Q3 2025 earnings is scheduled for Wednesday, April 23, 2025, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q3 2025 Earnings ReportSlide DeckFull Screen Slide DeckPowered by Get ResMed Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ResMed and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataRMD Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RMD Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. ResMed Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252$1.93$2.02$1.98Q2 20252$2.27$2.29$2.28Q3 20252$2.32$2.33$2.33Q4 20252$2.43$2.44$2.44FY 20258$8.95$9.08$9.02Q1 20262$2.33$2.66$2.50Q2 20262$2.42$2.80$2.61Q3 20262$2.48$2.55$2.52Q4 20262$2.48$2.67$2.58FY 20268$9.71$10.68$10.20Q1 20271$2.51$2.51$2.51Q2 20271$2.62$2.62$2.62Q3 20271$2.68$2.68$2.68 ResMed Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 4/23/2025(Estimated)-------1/30/2025Q2 2025$2.29$2.43+$0.14$2.34$1.27B-10/24/2024Q1 2025$2.03$2.20+$0.17$2.29$1.19B$1.22B8/1/2024Q4 2024$2.03$2.08+$0.05$2.18$1.22B$1.20B4/25/2024Q3 2024$1.91$2.13+$0.22$2.22$1.17B$1.20B1/24/2024Q2 2024$1.81$1.88+$0.07$2.34$1.15B$1.16B10/26/2023Q1 2024$1.63$1.64+$0.01$1.79$1.10B$1.10B8/3/2023Q4 2023$1.67$1.60 -$0.07$1.64$1.14B$1.12B4/27/2023Q3 2023$1.58$1.68+$0.10$1.78$1.05B$1.12B ResMed Earnings - Frequently Asked Questions When is ResMed's earnings date? ResMed has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 23rd, 2025 based off last year's report dates. Learn more on RMD's earnings history. Did ResMed beat their earnings estimates last quarter? In the previous quarter, ResMed (NYSE:RMD) reported $2.43 earnings per share (EPS) to beat the analysts' consensus estimate of $2.29 by $0.14. Learn more on analysts' earnings estimate vs. RMD's actual earnings. How can I listen to ResMed's earnings conference call? The conference call for ResMed's latest earnings report can be listened to online. Listen to Conference Call How can I read ResMed's conference call transcript? The conference call transcript for ResMed's latest earnings report can be read online. Read Transcript How much revenue does ResMed generate each year? ResMed (NYSE:RMD) has a recorded annual revenue of $4.93 billion. How much profit does ResMed generate each year? ResMed (NYSE:RMD) has a recorded net income of $1.02 billion. RMD has generated $8.47 earnings per share over the last four quarters. What is ResMed's price-to-earnings ratio? ResMed (NYSE:RMD) has a trailing price-to-earnings ratio of 25.13 and a forward price-to-earnings ratio of 22.48. The price/earnings-to-growth ratio is 1.53. What is ResMed's EPS forecast for next year? ResMed's earnings are expected to grow from $9.47 per share to $10.36 per share in the next year, which is a 9.40% increase. More Earnings Resources from MarketBeat Related Companies Medtronic Earnings Becton, Dickinson and Company Earnings Edwards Lifesciences Earnings IDEXX Laboratories Earnings DexCom Earnings STERIS Earnings Insulet Earnings Baxter International Earnings Hologic Earnings Globus Medical Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Archer Aviation Unveils NYC Network Ahead of Key Earnings Report3 Reasons to Like the Look of Amazon Ahead of EarningsTesla Stock Eyes Breakout With Earnings on DeckJohnson & Johnson Earnings Were More Good Than Bad—Time to Buy? Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions Ahead This page (NYSE:RMD) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ResMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ResMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
